BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 22592686)

  • 1. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2012 May; (5):CD002827. PubMed ID: 22592686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002827. PubMed ID: 27701752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002827. PubMed ID: 16625561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2003; (1):CD002827. PubMed ID: 12535440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for IgG and IgA paraproteinaemic neuropathy.
    Stork AC; Lunn MP; Nobile-Orazio E; Notermans NC
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD005376. PubMed ID: 25803231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for IgG and IgA paraproteinaemic neuropathy.
    Allen D; Lunn MP; Niermeijer J; Nobile-Orazio E
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005376. PubMed ID: 17253554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2013 Jun; (6):CD003280. PubMed ID: 23771584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM paraproteinaemic neuropathies.
    Nobile-Orazio E
    Curr Opin Neurol; 2004 Oct; 17(5):599-605. PubMed ID: 15367864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
    Benstead TJ; Chalk CH; Parks NE
    Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Swan AV; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2010 Nov; (11):CD003280. PubMed ID: 21069674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature.
    Gomez A; Hoffman JE
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):e101-8. PubMed ID: 27245314
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.
    Latov N
    Ann Neurol; 1995 May; 37 Suppl 1():S32-42. PubMed ID: 8968215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
    Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN
    Cochrane Database Syst Rev; 2013 Dec; (12):CD001797. PubMed ID: 24379104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.
    Mariette X; Chastang C; Clavelou P; Louboutin JP; Leger JM; Brouet JC
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):28-34. PubMed ID: 9221964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia.
    Weiss MD; Dalakas MC; Lauter CJ; Willison HJ; Quarles RH
    J Neuroimmunol; 1999 Mar; 95(1-2):174-84. PubMed ID: 10229128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002063. PubMed ID: 25238327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2012 Jul; (7):CD002063. PubMed ID: 22786476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein (MAG) antibody].
    Kawagashira Y; Koike H; Sobue G
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():440-5. PubMed ID: 26480739
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuropathies associated with monoclonal IgM anti-MAG antibodies].
    Pihan M; Decaux O; Marcorelles P; Bahon-Riedinger I; Lemercier S; Gainche-Salmon A; Doncker AV
    Rev Med Interne; 2012 Dec; 33(12):686-92. PubMed ID: 22726239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.